Stock Purchase Program

PDF viewPrint viewRSS FeedsEmail AlertSocial Media Sharing

Building Long-term Shareholder Value

Links to the Investor Day webcast here.

What's next for Cubist?

Cubist is moving forward confidently and successfully as an acute care-focused therapeutics company

Our recent financial results were announced on July 18, 2013.

Click Here to receive more information from Cubist Pharmaceuticals

Investor Relations Contact Info:

  • Cubist Investor Relations Contact
    Eileen C. McIntyre
    Vice President, Investor Relations
    (781) 860-8100

  • Eileen C. McIntyre
  • Public Accountants
    PriceWaterhouseCoopers LLP
    125 High Street
    Boston, MA 02110
    (617) 530-5000

  • Transfer Agent
    Computershare Trust Company, N.A.
    P.O. Box 43078
    Providence, RI 02940-3078
    (877) 282-1168

Copyright 2015, © SNL Financial LC  Terms of Use